Immediate Impact
6 hit
Citing Papers
Targeted therapeutic options and future perspectives for HER2-positive breast cancer
2019 Hit
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
2016 Hit
Works of Simona Giovannelli being referenced
A prognostic model based on nodal status and Ki-67 predicts the risk of recurrence and death in breast cancer patients with residual disease after preoperative chemotherapy
2009
Preoperative Chemotherapy plus Lapatinib or Trastuzumab or Both in HER2-Positive Operable Breast Cancer (CHERLOB Trial)
2008